Hesperidin
Spécifications
520-26-3Numéro CAS
208-288-1Numéro CE
(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-oneNom IUPAC
C28H34O15Formule chimique
610.6 g/molMasse molaire
hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesperetin 7-rutinoside; Ciratin; (S)-(-)-Hesperidin; DTXSID9044328; DIOSVEIN; E750O06Y6O; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one; DTXCID7024328; Hesperetin 7-O-rutinoside; CHEBI:28775; NSC-44184; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (S)-; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyl)oxy)-4-chromanon; NSC44184; Hesperidin 2S; 2S, Hesperidin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl)oxan-2-yl)oxy-2,3-dihydrochromen-4-one; Hesperetin Glycoside; RefChem:5881; Hesperetin 7 Rutinoside; Hesperetin 7 Rhamnoglucoside; 7-Rhamnoglucoside, Hesperetin; NDI 590; 208-288-1; Hesperetin 7-Rhamnoglucoside; NSC-31048; (s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one; Hesper bitabs; MFCD00075663; MLS001304066; (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hesperitin-7-rhamnoglucoside; Hesperidin (JAN); Hesperetin-rutinosid; Diosmin EP Impurity B; SMR000718775; HESPERIDIN [JAN]; C28H34O15; NSC 44184; Hesperedin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one; Aurantiamarin (Methyl Hesperidin); (2S)-Hesperidin; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; CCRIS 3940; Hesperetin-7-O-rutinoside; SR-01000799145; EINECS 208-288-1; BRN 0075140; Hespiridin; Cirmtin; UNII-E750O06Y6O; Hesperetin-7-O-rhamnoglucoside; Hesperidin CRS; NCGC00016481-01; (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one (Hesperidin); CAS-520-26-3; Hesperidin (natural); 3',5'-Dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on; Hesperidin (Standard); Hesperidin, >=80%; HESPERIDIN [MI]; DIOSMIN [NDI]; Prestwick3_000400; HESPERIDIN [VANDF]; EC 208-288-1; Glucopyranoside, hesperetin-7 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-; Hesperetin, 7-(6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); HESPERIDIN [MART.]; HESPERIDIN [USP-RS]; HESPERIDIN [WHO-DD]; SCHEMBL94586; BSPBio_000619; 5-18-05-00218 (Beilstein Handbook Reference); 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one, (S)-; 7-(6-O-Desoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon; cid_10621; Hesperidin, analytical standard; BPBio1_000681; CHEMBL449317; NDI 590 [FDMS]; orb1309991; orb3139587; SCHEMBL29397414; SCHEMBL29485712; BCBcMAP01_000136; BDBM61776; WLZ4715; HMS2096O21; HMS2233I03; HMS3713O21; HMS6018H22; (S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)chroma; MSK40133; Tox21_110448; EBC-27380; HY-15337R; LMPK12140451; s2309; AKOS015895450; CCG-208580; CS-5631; DB04703; KS-5308; OH08129; SMP1_000149; NCGC00179501-01; NCGC00179501-16; 4H-1-Benzopyran-4-one, 7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-; HY-15337; SY059206; AB00513829; H0049; Hesperidin, mixture with analogeous compounds; NS00008545; C09755; D01038; EN300-7419024; F809729; Q385937; Hesperidin, primary pharmaceutical reference standard; SR-01000799145-4; SR-01000799145-5; SR-01000799145-7; BRD-K38903228-001-02-8; BRD-K38903228-001-13-5; Hesperidin, European Pharmacopoeia (EP) Reference Standard; 3',5'-DIHYDROXY-4'-METHOXY-7-RUTINOSYLOXYFLAVAN-4-ONE; hesperetin 7-(6-O-alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside; Hesperidin, Pharmaceutical Secondary Standard; Certified Reference Material; 3',5,7-Trihydroxy-4'-methoxyflavanone-7-O-(6-O-a-L-rhamnopyranosyl)-b-D-glucopyranoside; Cirantin; Hesperetin 7-rhamnoglucoside; Hesperetin 7-rutinoside; Hesperidoside; Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-D-glucoside); (2S)-2-(4-methoxy-3-oxidanyl-phenyl)-7-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5R,6S)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-2,3-dihydrochromen-4-one; (2S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-3,4-dihydro-2H-1-benzopyran-4-one; (2S)-7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDRO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; (S)-7-[[6-O-(6-Deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; (S)-7-[[6-O-(6-Deoxy-|A-L-mannopyranosyl)-|A-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 4H-1-BENZOPYRAN-4-ONE, 7-((6-O-(6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)-.BETA.-D-GLUCOPYRANOSYL)OXY)-2,3-DIHYDO-5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-, (S)-; 5-HYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)-7-((6-O-.ALPHA.-L-RHAMNOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-4-CHROMANONSynonymes
Produits contenant Hesperidin
DAFLON 500 mg COMPRIMIDOS RECUBIERTOSDAFLON 500mg comprimidos recubiertos.DAFLON 500 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULADAFLON 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULADAFLON 500mg comprimidos recubiertosDAFLON 500 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAFLAVONOIDES ZENTIVA CONSEIL 500 mg, comprimé pelliculéFLAVONOIDES ZENTIVA CONSEIL 1000 mg, comprimé pelliculéFLAVONOIDES ARROW CONSEIL 500 mg, comprimé pelliculéFLAVONOIDES ARROW CONSEIL 1000 mg, comprimé pelliculé sécableAlgosin 500Daflavon
Page 1 sur 9
Services liés à Hesperidin
Entreprises vendant Hesperidin
Page 1 sur 7